Pyxis Oncology, Inc. (PYXS)
NASDAQ: PYXS · Real-Time Price · USD
1.300
-0.050 (-3.70%)
At close: Feb 13, 2026, 4:00 PM EST
1.340
+0.040 (3.08%)
After-hours: Feb 13, 2026, 6:15 PM EST
Pyxis Oncology Market Cap
Pyxis Oncology has a market cap or net worth of $80.94 million as of February 13, 2026. Its market cap has decreased by -15.98% in one year.
Market Cap
80.94M
Enterprise Value
23.76M
1-Year Change
-15.98%
Ranking
Category
Stock Price
$1.30
Market Cap Chart
Since the IPO on October 1, 2021, Pyxis Oncology's market cap has decreased from $523.75M to $80.94M, a decrease of -84.55%. That is a compound annual growth rate of -34.76%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 13, 2026 | 80.94M | 13.04% |
| Dec 31, 2025 | 71.60M | -22.81% |
| Dec 31, 2024 | 92.77M | 16.32% |
| Dec 29, 2023 | 79.75M | 70.77% |
| Dec 30, 2022 | 46.70M | -86.78% |
| Dec 31, 2021 | 353.33M | -32.54% |
| Oct 1, 2021 | 523.75M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Oncolytics Biotech | 90.35M |
| Biomea Fusion | 87.32M |
| aTyr Pharma | 87.07M |
| Spruce Biosciences | 85.55M |
| eXoZymes | 84.00M |
| OKYO Pharma | 83.14M |
| Champions Oncology | 82.76M |
| PolyPid | 82.10M |